National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

CC-8490
A benzopyran with potential antineoplastic activity. CC-8490 acts as a selective estrogen receptor modulator (SERM), inhibiting the proliferation of estrogen-sensitive breast cancer cells. This agent also inhibits growth and induces apoptosis of glioblastoma cells via a mechanism independent of estrogen receptor-related mechanisms. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:SPC8490



Previous:Caverject, CB10-277, CBT-1, CC-1088, CC-401
Next:CD20-targeted polypeptide TRU-015, CD3/CD28 costimulated vaccine-primed autologous T-cells, CD4+CD25+ regulatory T cells, CD40 agonist monoclonal antibody CP-870,893, CDDO

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov